Editors' ChoiceNeurodegenerative Disease

A QuICR test to diagnose Parkinson’s disease

See allHide authors and affiliations

Science Translational Medicine  13 Jan 2021:
Vol. 13, Issue 576, eabg1761
DOI: 10.1126/scitranslmed.abg1761


Refined conditions permit rapid detection of proteopathic α-synuclein seeds in cerebrospinal fluid from patients with Parkinson’s disease.

View Full Text

Stay Connected to Science Translational Medicine